PLXDC2 upregulation was also observed in primary postradiotherapy tumor tissues collected from patients with radioresistant HNSCC, suggesting that our research findings have a strong clinical relevance. The gene discussed is PLXDC2; the disease is head and neck squamous cell carcinoma.